Latest News

Latest News

News from the World Hepatitis Alliance

hepVoice March/April is out now

1 Apr 2020 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + COVID-19 message from WHA President, Su Wang;
 + New partnership to eliminate hepatitis C...

COVID-19. Information for people living with viral hepatitis

31 Mar 2020 Chris Wingrove

During the COVID-19 pandemic, the World Hepatitis Alliance (WHA) is committed to bringing you the most up to date information for people living with...

COVID-19 message from World Hepatitis Alliance president, Su Wang

25 Mar 2020 Lucy Ferrier

know the WHA family of members around the world will make it through this crisis together....

WHA features in Your Liver campaign

17 Mar 2020 Chris Wingrove

WHA recently worked with Health Awareness on the 2020 Your Liver campaign. A printed publication was enclosed within every copy of the Guardian...

Message from Su Wang, World Hepatitis Alliance President

16 Mar 2020 Chris Wingrove

Dear Colleagues, It is my honour to take up the role of President of the World Hepatitis Alliance (WHA) this year. It is a privilege to represent...

WHA launches new guide for members

27 Feb 2020 Chris Wingrove

The World Hepatitis Alliance has launched a new guide for advocates in countries that receive Global Fund support to use when making the case for co-...

hepinion: The African Union must provide leadership for hepatitis elimination

21 Feb 2020 Lucy Ferrier

By Dr Alioune Coulibaly, WHA Board Member for the AFRO Region In February the African Union met and the Presidency of the Union handed over from...

hepVoice February is out now

21 Feb 2020 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + New hepatitis progress to elimination data available; + Message from WHA's president, Su...

World Day of Social Justice: towards an equitable response to harm reduction and hepatitis

20 Feb 2020 Lucy Ferrier

Only through reaching marginalised communities with integrated, accessible, human rights-focussed and person-centred services will we close the inequalities gap and achieve social justice for people affected by viral hepatitis....

Catch up with our second webinar with FIND

18 Feb 2020 Chris Wingrove

Join Sonjelle Shilton, Deputy Head HCV Access at the Foundation for Innovative New Diagnostics (FIND), as she explores strategies to increase access...

World Hepatitis Alliance welcomes three new board members

6 Jan 2020 Lucy Ferrier

The World Hepatitis Alliance is delighted to welcome three new members to its executive board...

hepVoice December is out now

19 Dec 2019 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + Meet WHA's new board members; + WHO report: Ignoring the health of people in prisons now...

World Hepatitis Day 2019 Summary Report out now

18 Dec 2019 Lucy Ferrier

With photographs and details of World Hepatitis Alliance member activities, a summary of major commitments and announcements from national governments, and impressive impact statistics, the World Hepatitis Day 2019 Summary Report is designed to demonstrate the impact of World Hepatitis Day (WHD) and to provide inspiration to others planning WHD activities for 2020....

hepinion: 2019, a year to remember

16 Dec 2019 Lucy Ferrier

by Cary James, WHA CEO We have come to the end of another year and I believe it’s important that we take time to pause and briefly reflect on the...

Catch up on the FIND webinar on hepatitis C diagnostics

28 Nov 2019 Chris Wingrove

On Wednesday the 27th November we were joined by FIND for a webinar on the diagnositcs landscape of hepatitis C testing. If you missed the webinar...

hepVoice November is Out Now

20 Nov 2019 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + Global hepatology societies call for better hepatitis C testing and access to treatment; +...

hepinion: decentralisation and task shifting will accelerate the elimination of viral hepatitis

19 Nov 2019 Lucy Ferrier

We will not achieve the elimination of hepatitis C if we do not reach those most at-risk and most affected. The decentralisation of services will help us test, treat and cure marginalised and at-risk communities, wherever they are....

Nominate your candidate to stand for election as a WHA Regional Board Member.

7 Nov 2019 Isabel Bull

Nominations are open for candidates to stand for election as the World Hepatitis Alliance (WHA) Regional Board Members for the African (AFRO),...

hepVoice October is out now

21 Oct 2019 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: World Hepatitis Alliance welcomes 10 new members; Universal Health Coverage: what it means...

hepinion: global funders must join the fight for hepatitis elimination

16 Oct 2019 Lucy Ferrier

by Dr Philip Bruggman Earlier this month, the Global Fund met for its sixth replenishment meeting in Lyon, France, where it achieved its ambitious...

Pages

News from infohep

Will people with liver disease be prioritised for COVID-19 vaccination?

19 Jan 2021 Keith Alcorn
People with decompensated cirrhosis should be prioritised for COVID-19 vaccination and immunosuppressive treatment after a liver transplant should...

What's needed to eliminate hepatitis C in people with HIV in Scotland?

18 Jan 2021 Keith Alcorn
To eliminate hepatitis C in people with HIV in Scotland, healthcare providers will need to reach people not on HIV treatment and step up testing...

Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries

8 Jan 2021 Keith Alcorn
Public-sector hepatitis C treatment programmes have cured tens of thousands of people in lower- and lower-middle-income countries with the aid of low...

Semaglutide alone or in combination regimens shows promise for NASH

18 Dec 2020 Liz Highleyman
Semaglutide, a medication approved to treat type 2 diabetes, increased the likelihood of improvement in non-alcoholic steatohepatitis (NASH) without...

Lanifibranor improves NASH in 24-week trial

18 Dec 2020 Keith Alcorn
Twenty-four weeks of treatment with lanifibranor, a drug designed to treat NASH, improved liver fibrosis in 42% of people treated in a phase 2b...

Efruxifermin improves liver fat and fibrosis in people with NASH

15 Dec 2020 Keith Alcorn
Efruxifermin reduced liver fat and improved liver inflammation and fibrosis in the majority of people with NASH who received it in a phase 2a trial...

High hepatitis C cure rate achieved in New York prisons

9 Dec 2020 Keith Alcorn
Hepatitis C treatment in prisons can result in a high cure rate but people released from prison during treatment are less likely to be cured due to...

2.5 million people in Africa need urgent hepatitis B treatment

9 Dec 2020 Keith Alcorn
Around 2.5 million people with hepatitis B in sub-Saharan Africa already have cirrhosis and need immediate antiviral treatment, a systematic review...

Few countries will meet 2020 target for reducing viral hepatitis deaths

24 Nov 2020 Keith Alcorn
Around 1.1 million deaths were caused by viral hepatitis worldwide in 2019 and deaths due to hepatitis C are still rising despite the availability of...

Some hepatitis B patients can safely stop antivirals

24 Nov 2020 Liz Highleyman
Many people who take nucleoside/nucleotide antivirals for chronic hepatitis B can safely discontinue treatment, although this usually does not lead...